[144] Synopsys Inc SEC Filing
Form 144 notice for Synopsys, Inc. (SNPS) indicates a proposed sale of 3,655 shares of common stock through Morgan Stanley Smith Barney on 09/05/2025. The filing reports an aggregate market value of $2,228,709.35 and lists 155,160,938 shares outstanding. The securities were acquired on 09/05/2025 by stock option exercise and paid in cash on the same date. The filing also discloses a prior sale by Shelagh M Glaser of 7,310 shares on 06/06/2025 for $3,550,608.81. The form includes the seller's representation about absence of undisclosed material information.
- Complete disclosure of broker, share amount, acquisition method, and payment method in the Form 144
 - Prior sale history provided (7,310 shares sold on 06/06/2025), offering transparency on recent insider transactions
 - Attestation included that the seller does not possess undisclosed material information
 
- Insider sale of shares may be perceived negatively by some investors despite being routine
 - No 10b5-1 plan adoption date is indicated, so the sale may not be part of an established trading plan (noted as absent in the filing)
 
Insights
TL;DR Insider plans to sell stock acquired by option exercise; size appears small relative to outstanding shares.
The filing documents a routine Form 144 notice for 3,655 shares to be sold through Morgan Stanley Smith Barney on 09/05/2025. The securities were acquired the same day via stock option exercise and paid for in cash, suggesting a planned disposition of recently exercised shares rather than a sale from long-term holdings. Prior sale activity by the same individual (7,310 shares on 06/06/2025) is disclosed, providing recent liquidity context. For investors this is a standard insider disclosure but not, by itself, a material corporate event.
TL;DR The notice is a compliance disclosure; timing and prior sales warrant monitoring but raise no immediate governance red flags.
Form 144 properly identifies broker, share amount, acquisition method, and payment method. Acquisition via stock option exercise and same-day planned sale is consistent with post-exercise disposition. The filing includes the statutory attestation about material undisclosed information, which is required. No indication in this document of rule 10b5-1 reliance date or other special arrangements; absence of that date should be noted by compliance reviewers if relevant.